Aticaprant
Aticaprant (pronounced: /ætɪˈkæprænt/) is a pharmaceutical drug currently under development for the treatment of various allergic diseases. The drug is a potent and selective histamine H4 receptor antagonist.
Etymology
The term "Aticaprant" is a coined name, with no specific etymology. It follows the common naming convention for pharmaceutical drugs, which often end in "-prant".
Pharmacology
Aticaprant works by blocking the histamine H4 receptor, a protein involved in immune response and inflammation. By inhibiting this receptor, Aticaprant can potentially reduce symptoms associated with allergic diseases.
Clinical Trials
Aticaprant is currently in the clinical trial phase. Early studies have shown promise in treating conditions such as atopic dermatitis, asthma, and allergic rhinitis. However, more research is needed to confirm these findings and determine the drug's safety and efficacy.
Related Terms
- Histamine H4 receptor
- Pharmaceutical drug
- Allergic diseases
- Atopic dermatitis
- Asthma
- Allergic rhinitis
See Also
External links
- Medical encyclopedia article on Aticaprant
- Wikipedia's article - Aticaprant
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski